Lars Gedda
Lars Gedda
Verifierad e-postadress på kemi.uu.se
Citeras av
Citeras av
111In-benzyl-DTPA–ZHER2: 342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors
V Tolmachev, FY Nilsson, C Widström, K Andersson, D Rosik, L Gedda, ...
Journal of Nuclear Medicine 47 (5), 846-853, 2006
Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents
E Bohl Kullberg, N Bergstrand, J Carlsson, K Edwards, M Johnsson, ...
Bioconjugate chemistry 13 (4), 737-743, 2002
Gefitinib Induces Epidermal Growth Factor Receptor Dimers Which Alters the Interaction Characteristics with 125I-EGF
H Björkelund, L Gedda, P Barta, M Malmqvist, K Andersson
PLoS One 6 (9), e24739, 2011
Combining phage and staphylococcal surface display for generation of ErbB3-specific Affibody molecules
N Kronqvist, M Malm, L Göstring, E Gunneriusson, M Nilsson, ...
Protein Engineering, Design & Selection 24 (4), 385-396, 2011
Panchromatic ternary polymer dots involving sub-picosecond energy and charge transfer for efficient and stable photocatalytic hydrogen evolution
A Liu, L Gedda, M Axelsson, M Pavliuk, K Edwards, L Hammarström, ...
Journal of the American Chemical Society 143 (7), 2875-2885, 2021
Engineering and characterization of a bispecific HER2× EGFR‐binding affibody molecule
M Friedman, S Lindström, L Ekerljung, H Andersson‐Svahn, J Carlsson, ...
Biotechnology and applied biochemistry 54 (2), 121-131, 2009
Ligand liposomes and boron neutron capture therapy
J Carlsson, EB Kullberg, J Capala, S Sjöberg, K Edwards, L Gedda
Journal of neuro-oncology 62, 47-59, 2003
Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy
S Sjöberg, J Carlsson, H Ghaneolhosseini, L Gedda, T Hartman, ...
Journal of neuro-oncology 33, 41-52, 1997
Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin
X Wu, A Wanders, P Wardega, B Tinge, L Gedda, S Bergstrom, L Sooman, ...
British journal of cancer 100 (2), 334-343, 2009
Flow cytometric in situ proximity ligation analyses of protein interactions and post‐translational modification of the epidermal growth factor receptor family
KJ Leuchowius, I Weibrecht, U Landegren, L Gedda, O Söderberg
Cytometry Part A: The Journal of the International Society for Advancement …, 2009
Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor
J Carlsson, L Gedda, C Grönvik, T Hartman, A Lindström, P Lindström, ...
International Journal of Radiation Oncology* Biology* Physics 30 (1), 105-115, 1994
Development and in vitro studies of epidermal growth factor− dextran conjugates for boron neutron capture therapy
L Gedda, P Olsson, J Pontén, J Carlsson
Bioconjugate chemistry 7 (5), 584-591, 1996
Comparing the epidermal growth factor interaction with four different cell lines: intriguing effects imply strong dependency of cellular context
H Björkelund, L Gedda, K Andersson
PloS one 6 (1), e16536, 2011
[177Lu]Pertuzumab: Experimental Therapy of HER-2–Expressing Xenografts
M Persson, L Gedda, H Lundqvist, V Tolmachev, H Nordgren, ...
Cancer research 67 (1), 326-331, 2007
[177Lu]pertuzumab: experimental studies on targeting of HER-2 positive tumour cells
M Persson, V Tolmachev, K Andersson, L Gedda, M Sandström, ...
European journal of nuclear medicine and molecular imaging 32, 1457-1462, 2005
Tumor-cell targeted epidermal growth factor liposomes loaded with boronated acridine: uptake and processing
EB Kullberg, M Nestor, L Gedda
Pharmaceutical research 20, 229-236, 2003
Cellular effects of HER3-specific affibody molecules
L Göstring, M Malm, I Höidén-Guthenberg, FY Frejd, S Ståhl, J Löfblom, ...
PloS one 7 (6), e40023, 2012
Closo-Dodecaborate(2-) as a Linker for Iodination of Macromolecules. Aspects on Conjugation Chemistry and Biodistribution
V Tolmachev, J Koziorowski, I Sivaev, H Lundqvist, J Carlsson, A Orlova, ...
Bioconjugate chemistry 10 (3), 338-345, 1999
Cellular processing of 125I-and 111In-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells
A Orlova, A Bruskin, A Sjöström, H Lundqvist, L Gedda, V Tolmachev
Nuclear medicine and biology 27 (8), 827-835, 2000
A new antibody recognizing the vIII mutation of human epidermal growth factor receptor
L Öhman, L Gedda, G Hesselager, R Larsson, M Nister, T Stigbrand, ...
Tumor biology 23 (2), 61-69, 2002
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20